Detalhe da pesquisa
1.
Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
J Virol
; : e0071424, 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809021
2.
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report.
Clin Infect Dis
; 71(11): 2872-2879, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31784751
3.
Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017.
Emerg Infect Dis
; 26(4): 760-763, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32186496
4.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
5.
New Lineage of Lassa Virus, Togo, 2016.
Emerg Infect Dis
; 24(3): 599-602, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29460758
6.
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.
PLoS Med
; 14(10): e1002402, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985239
7.
Variability of interferon-λ induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors.
J Gen Virol
; 98(10): 2447-2453, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28984239
8.
The microtubule motor protein KIF13A is involved in intracellular trafficking of the Lassa virus matrix protein Z.
Cell Microbiol
; 15(2): 315-34, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23279019
9.
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.
Front Immunol
; 13: 857481, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35493467
10.
CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
Viruses
; 13(9)2021 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34578344
11.
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
Lancet Infect Dis
; 21(4): 507-516, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33065039
12.
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies.
Sci Rep
; 10(1): 14289, 2020 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868837
13.
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.
NPJ Vaccines
; 5(1): 71, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32802410
14.
Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in Germany.
Genome Announc
; 4(5)2016 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27660771
15.
Multifunctional nature of the arenavirus RING finger protein Z.
Viruses
; 4(11): 2973-3011, 2012 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23202512